Antiarrhythmic and cardioprotective substituted -1(2H)Isoquinolines, process for their production, medicament containing them and their use for the production of a medicament for combating heart failures
申请人:HOECHST AKTIENGESELLSCHAFT
公开号:EP0590455A1
公开(公告)日:1994-04-06
Described are guanidinocarbonyl isoquinolines I,
with R(1) hydrogen, (amino)(cyclo)(aryl)alk(en)yl, (heteroaryl); R(2) hydrogen, halogen, alkyl, or Aryl; G
X(2), X(3) and X(4) hydrogen, halogen, nitro, amino, alkyl, sulfonamide, (mono)(di)(lower alkyl)(amino), benzyloxy, hydroxy; X(1) hydrogen, oxygen, sulfur and NR(7)R(8), and their pharmaceutically acceptable salts; described is also the process for their prepara-tion, their use as medicaments, and medicaments containing them for treating congestive heart failure, arrhythmic conditions as well as cardioprotective agents in mammals.
所描述的是胍基异喹啉 I、
R(1) 氢、(氨基)(环)(芳基)烷(烯)基、(杂芳基); R(2) 氢、卤素、烷基或芳基; G
X(2)、X(3)和 X(4)氢、卤素、硝基、氨基、烷基、磺酰胺、(一)(二)(低级烷基)(氨基)、苄氧基、羟基;X(1)氢、氧、硫和 NR(7)R(8),以及它们的药学上可接受的盐;还描述了它们的制备过程、它们作为药物的用途,以及含有它们的用于治疗充血性心力衰竭、心律失常病症和哺乳动物心脏保护剂的药物。